You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Complement-inhibitor Protein

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Paroxysmal Nocturnal Hemoglobinuria Trial in Whittier (Ravulizumab, Pozelimab, Cemdisiran)

Recruiting
  • Paroxysmal Nocturnal Hemoglobinuria
  • Whittier, California
  • +8 more
Nov 29, 2022

Paroxysmal Nocturnal Hemoglobinuria (PNH) Trial in Worldwide (Iptacopan (LNP023))

Active, not recruiting
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
  • Iptacopan (LNP023)
  • Tianjin, Tianjin, China
  • +11 more
Nov 21, 2022

Neuromyelitis Optica Spectrum Disorder, NMOSD, AQP4+ NMOSD Trial

Not yet recruiting
  • Neuromyelitis Optica Spectrum Disorder
  • +2 more
    • (no location specified)
    Jul 21, 2023

    Paroxysmal Nocturnal Hemoglobinuria Trial (NM8074)

    Not yet recruiting
    • Paroxysmal Nocturnal Hemoglobinuria
    • (no location specified)
    Jan 17, 2023

    Periodontal Diseases Trial in Chennai (Non surgical periodontal therapy)

    Not yet recruiting
    • Periodontal Diseases
    • Non surgical periodontal therapy
    • Chennai, Tamilnadu, India
    • +1 more
    Apr 26, 2023

    Paroxysmal Nocturnal Hemoglobinuria (PNH) Trial in Worldwide (BCX9930 monotherapy, Placebo)

    Active, not recruiting
    • Paroxysmal Nocturnal Hemoglobinuria (PNH)
    • BCX9930 monotherapy
    • Placebo
    • Ampang, Malaysia
    • +3 more
    Dec 15, 2022

    Lupus Nephritis Trial in Shanghai (68Ga-FAPI-04 PET)

    Recruiting
    • Lupus Nephritis
    • 68Ga-FAPI-04 PET
    • Shanghai, China
      Ruijin Hospital
    May 4, 2023

    Paroxysmal Nocturnal Hemoglobinuria Trial (Danicopan)

    Recruiting
    • Paroxysmal Nocturnal Hemoglobinuria
    • Baltimore, Maryland
    • +4 more
    Feb 1, 2023

    C3 Glomerulopathy, Membranoproliferative Glomerulonephritis, Complement Abnormality Trial in Sweden (Aliskiren, Enalapril)

    Recruiting
    • C3 Glomerulopathy
    • +4 more
    • Gothenburg, Sweden
    • +3 more
    Jan 4, 2022

    Inhibitor of Apoptosis Protein Overexpression on Recurrence Rate

    Not yet recruiting
    • Cancer of Cervix
    • Apoptosis
    • Immunohistochemistry
    • (no location specified)
    Nov 17, 2023

    Esophageal Achalasia Trial in Marseille, Montpellier, Nîmes (Protein pump inhibitor therapy systematically)

    Recruiting
    • Esophageal Achalasia
    • Protein pump inhibitor therapy systematically
    • Marseille, France
    • +3 more
    Jun 2, 2023

    Novel Antidiabetic Drug Combined With Angiotensin

    Recruiting
    • Type 2 Diabetes
    • Antidiabetic Drugs
      • Beijing, Beijing, China
      • +1 more
      Jun 20, 2023

      PNH, Hemolysis Trial in Beijing (CAN106 20 mg/kg, CAN106 40 mg/kg, CAN106 80 mg/kg)

      Recruiting
      • PNH
      • Hemolysis
      • CAN106 20 mg/kg
      • +2 more
      • Beijing, Beijing, China
        Peking Union Medical College Hospital
      Sep 10, 2022

      Astrocytoma, Grades II, III and IV, Glioblastoma Multiforme, Giant Cell Glioblastoma Trial run by the National Cancer Institute

      Recruiting
      • Astrocytoma, Grades II, III and IV
      • +4 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 31, 2023

      Healthy Volunteers Trial in San Francisco (Rosuvastatin, Rosuvastatin (Inhibitor arm), Eltrombopag)

      Recruiting
      • Healthy Volunteers
      • San Francisco, California
        Ucsf Ctsi Crc
      Nov 29, 2022

      Healthy Adults Trial in Daytona Beach (Adagrasib, Eltrombopag + adagrasib)

      Recruiting
      • Healthy Adults
      • Daytona Beach, Florida
        Fortrea Clinical Research Unit Daytona Beach (Labcorp Clinical R
      Jun 29, 2023

      Primary IgA Nephropathy Trial (RO7434656, Placebo)

      Not yet recruiting
      • Primary IgA Nephropathy
      • (no location specified)
      Mar 22, 2023

      Atypical Hemolytic Uremic Syndrome Trial in Worldwide (Iptacopan)

      Recruiting
      • Atypical Hemolytic Uremic Syndrome
      • Torrance, California
      • +19 more
      Aug 10, 2022

      Traumatic Brain Injury, Trauma, Head Trial in Den Haag, Leiden, Rotterdam (C1 Inhibitor, Human, Placebo)

      Recruiting
      • Traumatic Brain Injury
      • Trauma, Head
      • C1 Inhibitor, Human
      • Placebo
      • Den Haag, Netherlands
      • +2 more
      Sep 6, 2021

      Paroxysmal Nocturnal Hemoglobinuria Trial in China (KP104)

      Not yet recruiting
      • Paroxysmal Nocturnal Hemoglobinuria
      • Beijing, China
      • +3 more
      Jul 25, 2022

      Malignant Tumor, Positron Emission Tomography, Fibroblast Activation Protein Inhibitor Trial in Beijing (68Ga-TCR-FAPI PET/CT)

      Recruiting
      • Malignant Tumor
      • +2 more
      • 68Ga-TCR-FAPI PET/CT
      • Beijing, China
        Peking University Cancer Hospital
      Oct 19, 2023

      Fibroblast Activation Protein Inhibitor PET/CT Imaging in

      Recruiting
      • Gastrointestinal Cancer
      • Fibroblast activation protein inhibitor PET/CT imaging
      • Wuhan, Hubei, China
        Zhongnan Hospital of Wuhan University
      Jul 14, 2022

      Solid Tumor, Unspecified, Adult Trial in Meldola (68 Gallium -Fibroblast Activating Protein Inhibitor -46 Positron emission

      Recruiting
      • Solid Tumor, Unspecified, Adult
      • 68 Gallium -Fibroblast Activating Protein Inhibitor -46 Positron emission tomography / Computerized tomography
      • Meldola, Forlì Cesena, Italy
        IRCCS Istituto ROmagnolo per lo Studio dei Tumori "Dino Amadori"
      Nov 15, 2023

      Cancer, Peritoneal Carcinomatosis Trial in Brussels (FAPI PET/CT)

      Recruiting
      • Cancer
      • Peritoneal Carcinomatosis
      • FAPI PET/CT
      • Brussels, Belgium
        Institut Jules Bordet
      Sep 25, 2023

      Cancer Trial in Changsha (Protein Kinase Inhibitor)

      Recruiting
      • Cancer
      • Protein Kinase Inhibitor
      • Changsha, Hunan, China
        Central South University
      Jun 23, 2022